Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome
Open Access
- 19 April 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (17)
Abstract
Significance: Our work uncovers mechanisms by which tumor cells impact tumor-associated macrophages in human triple-negative breast cancer. Via extracellular vesicles (EVs), these tumors promote macrophages with proinflammatory features, correlated with better clinical outcome. Our results suggest exploration of these EVs as tools, alone, or in combination with other therapies, to promote a favorable environment for the generation of anti-tumor immune responses.Keywords
This publication has 73 references indexed in Scilit:
- The M1 and M2 paradigm of macrophage activation: time for reassessmentF1000Prime Reports, 2014
- Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage ActivationImmunity, 2014
- Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMPNature, 2013
- Tumor-Associated Macrophages as a Paradigm of Macrophage Plasticity, Diversity, and PolarizationArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- INTERFEROME v2.0: an updated database of annotated interferon-regulated genesNucleic Acids Research, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunityNature, 2009
- The chemokine system in diverse forms of macrophage activation and polarizationTrends in Immunology, 2004
- CSF-1 regulation of the wandering macrophage: complexity in actionTrends in Cell Biology, 2004